Fig. 5
From: Modeling neoplastic disease with spheroids and organoids
Current preclinical cancer research. 3D systems combined with new technologies such as organ-on-a-chip and 3D bioprinting could fill the gap between traditional 2D cell culture and animal models, producing more reliable data while also reducing costs, time to results, and political/ethical issues before their transition to clinical practice